1 Hepatobiliary Center of the First Affiliated Hospital, Nanjing Medical University, Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing, Jiangsu 210029, China
Find articles by Jian Gu1 Hepatobiliary Center of the First Affiliated Hospital, Nanjing Medical University, Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing, Jiangsu 210029, China
Find articles by Qing Shao1 Hepatobiliary Center of the First Affiliated Hospital, Nanjing Medical University, Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing, Jiangsu 210029, China
Find articles by Jinren Zhou1 Hepatobiliary Center of the First Affiliated Hospital, Nanjing Medical University, Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing, Jiangsu 210029, China
Find articles by Qiuyang Chen1 Hepatobiliary Center of the First Affiliated Hospital, Nanjing Medical University, Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing, Jiangsu 210029, China
Find articles by Ling Lu1 Hepatobiliary Center of the First Affiliated Hospital, Nanjing Medical University, Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing, Jiangsu 210029, China
∗ Corresponding author nc.ude.umjn@gnilvl 2 These authors contributed equally 3 Technical contact 4 Lead contact Copyright © 2022 The Author(s)This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
This study did not generate datasets/codes.
Regulatory T cells (Tregs) can inhibit the occurrence of autoimmune diseases and increase the activation threshold of the immune response. Here, we present schemes for the isolation and culture of natural human regulatory T cells (nTregs) and in vitro-induced Tregs (iTregs). Appropriate concentrations of TGF-β, IL-2, retinoic acid (atRA), and rapamycin were used to promote proliferation to meet sample needs in basic research, especially in technologies such as sequencing.
For complete details on the use and execution of this protocol, please refer to Lu et al. (2014a) and Gu et al. (2022).
Subject areas: Cell biology, Cell culture, Cell isolation, ImmunologyPublisher’s note: Undertaking any experimental protocol requires adherence to local institutional guidelines for laboratory safety and ethics.
Regulatory T cells (Tregs) can inhibit the occurrence of autoimmune diseases and increase the activation threshold of the immune response. Here, we present schemes for the isolation and culture of natural human regulatory T cells (nTregs) and in vitro-induced Tregs (iTregs). Appropriate concentrations of TGF-β, IL-2, retinoic acid (atRA), and rapamycin were used to promote proliferation to meet sample needs in basic research, especially in technologies such as sequencing.
Tregs play important roles in autoreactive lymphocyte suppression and regulation of immune homeostasis. This protocol describes a procedure to extract nTreg and naive CD4 + T cells from the peripheral blood of volunteers and induce their expansion.
Due to the low content of nTreg in peripheral blood, we usually extract 100 mL peripheral blood mononuclear lymphocyte cells from the peripheral blood of a single volunteer and then further extract nTreg. To consider the experimental cost, we will extract 100 mL of peripheral blood from volunteers and extract naïve CD4 + T cells (Lu et al., 2010).
Selecting the appropriate culture environment and culture system, and adding the appropriate concentration of cytokines, such as IL-10, TGF-β, atRA, and rapamycin (Lu et al., 2014b), are essential for inducing and expanding Tregs (Lu et al., 2014a). Therefore, before starting, the reagents and equipment listed in the following and attached key resources table should be prepared.
All research work can only be carried out after obtaining the approval of the Institutional Review Board (IRB).
Peripheral blood mononuclear lymphocytes from normal volunteers were obtained from the First Affiliated Hospital of Nanjing Medical University under protocols approved by the ethics committee of the First Affiliated Hospital of Nanjing Medical University (2021-SRFA-346).
Contact volunteers in advance with precautions and signed informed consent forms according to local ethics committee requirements.
Check the equipment status and consumables expiration date.Dispense the following required reagents into the corresponding solutions and store them in aliquots.
Note: Transfer of volunteer blood to the laboratory requires a transfer box and ice packs.
REAGENT or RESOURCE | SOURCE | IDENTIFIER |
---|---|---|
Antibodies | ||
Alexa Fluor® 647 anti-human FOXP3 Antibody (clone 206D) (Working dilution: 1:100) | BioLegend | Cat # 320114, RRID: AB_439753 |
APC anti-human CD45RA Antibody (clone HI100) (Working dilution: 1:100) | BioLegend | Cat # 304112, RRID: AB_314415 |
APC anti-human CD8a Antibody (clone RPA-T8) (Working dilution: 1:100) | BioLegend | Cat # 301014, RRID: AB_314132 |
Brilliant Violet 510™ anti-human CD4 Antibody (clone OKT4) (Working dilution: 1:100) | BioLegend | Cat # 357420, RRID: AB_2561377 |
FITC anti-human CD127 (IL-7Rα) Antibody (clone A019D5) (Working dilution: 1:100) | BioLegend | Cat # 351312, RRID: AB_10933247 |
FITC anti-human CD4 Antibody (clone OKT4) (Working dilution: 1:100) | BioLegend | Cat # 357406, RRID: AB_571950 |
PE anti-human CD25 Antibody (clone BC96) (Working dilution: 1:100) | BioLegend | Cat # 302606, RRID: AB_314275 |
PerCP/Cyanine5.5 anti-human CD25 Antibody (clone M-A251) (Working dilution: 1:100) | BioLegend | Cat # 302626, RRID: AB_2561978 |
PerCP/Cyanine5.5 anti-human CD4 Antibody (clone RPA-T4) (Working dilution: 1:100) | BioLegend | Cat # 357414, RRID: AB_893328 |
Biological samples | ||
Human blood | Healthy volunteers, male and female, aged 18–65 years | Approved by the ethics committee of the First Affiliated Hospital of Nanjing Medical University (2021-SRFA-346) |
Chemicals, peptides, and recombinant proteins | ||
CellTrace™ CFSE Cell Proliferation Kit, for flow cytometry | Invitrogen | C34554 |
Dimethyl Sulfoxide, 950 mL | Thermo Scientific | 20688 |
Dynabeads™ Human T-Activator CD3/CD28 | Gibco | 11132D |
eBioscience™ Foxp3 / Transcription Factor Staining PBS Set | Invitrogen | 00-5523-00 |
Flow Cytometry Staining Buffer (FACS buffer) | Invitrogen | 00-4222-26 |
LIVE/DEAD™ Fixable Near-IR Dead Cell Stain | Invitrogen | L34976 |
Lymphocyte Serum-Free Medium | Corning | 88-581-CM |
Lymphoprep™ | STEMCELL | Cat # 07851 |
PBS (1×) | Gibco | 20012027 |
Rapamycin | MCE | HY-10219 |
Recombinant Human IL-2 | PeproTech | Cat # 200-02 |
Recombinant Human TGF-beta 1 Protein | R&D | Cat # 240-B-002 |
Retinoic acid | MCE | HY-14649 |
Trypan Blue Stain (0.4%) | Gibco | 15250061 |
Critical commercial assays | ||
CD127 MicroBead Kit, human | Miltenyi Biotec | Cat # 130-094-945 |
CD4 + CD25 + Regulatory T Cell Isolation Kit, human | Miltenyi Biotec | Cat # 130-091-301 |
CD8 MicroBeads, human | Miltenyi Biotec | Cat # 130-045-201 |
Human interleukin-10 (IL-10) ELISA Kit | Jingmei | JM-03221H1 |
Human transforming growth factorβ1TGF-β 1 ELISA KIT | Jingmei | JM-03245H1 |
Mini&MidiMACS TM Starting Kits (MS, LS) | Miltenyi Biotec | Cat #130-042-501 |
Naive CD4 + T Cell Isolation Kit II, human | Miltenyi Biotec | Cat # 130-094-131 |
Software and algorithms | ||
Excel | Microsoft | N/A |
FlowJo 10.6.1 | BD | https://www.flowjo.com/solutions/flowjo/downloads |
GraphPad Prism 9 | GraphPad Inc | https://www.graphpad.com/scientific-software/prism/ |
Other | ||
10 mL serological pipette | Labsecet | SP-003-10 |
96 Well Cell Culture Cluster | Corning | Cat # 3599 |
Anticoagulation Solution (Sodium citrate) | JIERUI | https://www.weigaoholding.com/product_info/164.html |
BD FACS ARIA II SORP (Special Order Research Product) | BD | FACS Aria™ II |
Beckman Allegra X-15R Benchtop Centrifuge | Beckman Counter | 8043-30-1206 |
Blood Collection Tubes | BD | 367525 |
Centrifuge tube, 15 mL | Labsecet | CT-002-15 |
Centrifuge tube, 50 mL | Labsecet | CT-002-50 |
Countess™ 3 Automated Cell Counter | Invitrogen | AMQAX2000 |
Countess™ Cell Counting Chamber Slides | Invitrogen | C10228 |
DynaMag™-15 | Invitrogen | 12301D |
Finnpipette 9501 C1 Pipet Controller, 1–100 ML | Thermo Scientific | CN-22800-20 |
Forma™ Direct Heat CO2 Incubator, 184 L | Thermo Scientific | 320 |
MCS®+ 9000 Mobile Platelet Collection System | Haemonetics | https://persona.haemonetics.com/en/products/devices/blood-center-devices/mcs-9000 |
Peripheral Blood Stem Cell Disposable Set | Haemonetics | Cat #0971E-00 |
25cm 2 Rectangular Canted Neck Cell Culture Flask with Plug Seal Cap | Corning | Cat # 430168 |
Corning 75cm 2 Rectangular Canted Neck Cell Culture Flask with Plug Seal Cap | Corning | Cat # 430720 |
Round Bottom Polystyrene Tubes | Falcon | 352054 |
Timing: 3 h for extracting human peripheral blood mononuclear lymphocytes, 3 h for separating nTregs
In this step, human peripheral blood mononuclear lymphocytes were first extracted by MCS®+ 9000 Mobile Platelet Collection System, and then human nTregs were purified by magnetically activated cell sorting (MACS). Alternatively, you can get commercially available buffy coats and skip step 1.
Use MCS®+ 9000 Mobile Platelet Collection System to extract 100 mL PBMCs from the peripheral blood of volunteers.
Fully mix PBS and PBMCs with the same volume in centrifuge tubes.Place the same volume of lymphoprep ™ below the mixing solution. Indeed the PBS: PBMC is layered ON TOP of the Lymphoprep solution and not vice versa.
CRITICAL: Due to solution density issues, take care of the Lymphoprep™. Make sure it is not mixed with blood and PBS before centrifugation.
Take the middle white film layer after centrifugation (393 g, 23 min, acceleration 0, acceleration 0, 4°C) ( Figure 1 A).
Isolation of natural human regulatory T cells (nTregs) (A) Human peripheral blood mononuclear lymphocytes (PBMCs) were sorted from samples extracted by MCS®+ 9000 Mobile Platelet Collection System. (B) The number of cells obtained by magnetic column sorting at each step. On the first negative selection (NS) step, CD127 - cells were sorted from PBMCs. On the second negative selection step, CD4 + CD127 - cells were got. On the third positive selection (PS) step, CD4 + CD25 + CD127 - nTregs were finally received. (C) The purity of CD4 + CD127 - cells were identified after NS selection, and the purity of CD4 + CD25 + CD127 - nTregs were identified after PS selection on day 0. (D) State of nTregs after selection on day 0 under the microscope (10×).
Wash by adding one volume of PBS (167 g, 5 min, acceleration 9, deceleration 9, 4°C), and collect the cell pellet. (e.g., 1 mL leukocyte suspension with 1 mL PBS).
Add the same volume of PBS as the supernatant, and repeat step.1.d 3–5 times until the liquid was clear.
Collect all the cell pellets and count PBMCs.Note: All of the work with Lymphoprep needs to be at 25°C. Temperature fluctuations will result in poor separation. And all subsequent work (after PBMC isolation) is performed ‘ON ICE’.